Together we make an impact in patients’ lives and the future of healthcare

Registry Study

We were asked by a pharma company to evaluate adherence and retention for one of their therapies and to compare the results with the rest of the market.

The Swedish national drug registry is almost unique in the world, it contains all fulfilled prescriptions from the 1st of July 2005 up until today. Over the years we have done more than 60 studies in the registry, either in the registry only or in combination with other registry data.

We have developed a code library that goes through the huge amount of data and calculates key performance indicators like how long the patients stay on therapy and how well they adhere to the recommendations from healthcare.

In the current example the material contained 11 million prescriptions and data from approximately 110 000 patients were included in the study.


Cecilia Sällström